Skip to main content

Table 1 Summary of the twenty-three included studies

From: Prognostic effect of lncRNA SNHG7 on cancer outcome: a meta and bioinformatic analysis

  Study Origin of population Study design Disease Number Stage SNHG7 assay Survival analysis Metastasis analysis Hazard ratios Follow-up Months
1 Chen 2018 [10] China R Bladder cancer 92 I-III/IV qRT-PCR OS LNM/DM K-M 60
2 Cheng 2019 [25] China R Pancreatic cancer 40 I-II/III-IV qRT-PCR OS LNM K-M 50
3 Chi 2018 [49] China R Neuroblastoma 92 I-IIA/IIB-IV qRT-PCR OS LNM K-M 60
4 Hu 2019 [35] China R Colorectal cancer 738 NA TCGA database OS NA K-M 14
5 Jia 2020 [36] China R Neuroblastoma 45 I-II/III-IV qRT-PCR OS NA K-M 60
6 Jiang 2020 [37] China R Breast cancer 57 I-II/III-IV qRT-PCR NA LNM NA NA
7 Li 2018 [38] China R Colorectal cancer 70 I-II/III-IV qRT-PCR OS/DFS LNM/DM K-M 60
8 Pang 2020 [39] China R Non-small cell lung cancer 42 I-II/III-IV qRT-PCR NA LNM NA NA
9 Qi 2018 [20] China R Prostate cancer 42 II/III-IV qRT-PCR OS LNM K-M 60
10 Shan 2018 [24] China R Colorectal cancer 48 I-II/III-IV qRT-PCR OS LNM/DM K-M 72
11 Shen 2020 [40] China R Hepatocellular carcinoma 100 I-II/III-IV qRT-PCR OS/PFS LNM K-M 60
12 Wang 2019 [18] China R Thyroid cancer 64 I-II/III-IV qRT-PCR NA LNM NA NA
13 Wang 2020 [23, 27, 41] China R Melanoma 80 I-II/III-IV qRT-PCR OS LNM/DM K-M 48
14 Wu 2019 [6] China R Hypopharyngeal Cancer 73 I-II/III-IV qRT-PCR OS LNM/DM K-M 60
15 Wu 2020 [42] China R Cervical Cancer 51 I-II/III-IV qRT-PCR OS LNM K-M 60
16 Xia 2019 [50] China R Prostate cancer 127 I-II/III-IV qRT-PCR OS LNM/DM HR/K-M 60
17 Xie 2020 [43] China R Hepatocellular carcinoma 80 NA qRT-PCR OS NA K-M 60
18 Yang 2019 [44] China R Hepatocellular carcinoma 80 NA qRT-PCR OS NA K-M 60
19 Zeng 2019 [45] China R Cervical cancer 60 I-II/III-IV qRT-PCR OS LNM HR/K-M 60
20 Zhang 2019 [7] China R Gastric cancer 162 I-II/III-IV qRT-PCR OS LNM/DM K-M 96
21 Zhang 2020 [28, 46, 47] China R Colorectal cancer 96 I/II-III qRT-PCR OS LNM K-M 40
22 Zhao 2020 [48] China R Cervical cancer 45 I-II/III-IV qRT-PCR OS LNM K-M 50
23 Zhong 2018 [21] China R Bladder cancer 134 I/II-IV qRT-PCR NA LNM NA 36
  1. BC breast cancer, BLC Bladder cancer, CC cervical cancer, CRC colorectal cancer, HCC hepatocellular carcinoma, GA gastric cancer, PC prostate cancer, PAC Pancreatic cancer, TC thyroid carcinoma, HC Hypopharyngeal Cancer, NSCLC Non-small cell lung cancer